trial · primary record
AZD4512
B-cell Non-Hodgkin Lymphoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 164 |
| Primary completion | 2029-02-15 |
| Primary endpoint | Percentage of participants with dose-limiting toxicities (DLTs) during the DLT period |
| Registry ID | NCT07123454 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:05.084Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07123454
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.